Victory Capital Management Decreases Holdings in Merit Medical Systems,

☀️Trending News

Victory Capital Management Inc. recently decreased its holdings in Merit Medical Systems ($NASDAQ:MMSI), Inc. shares. This comes as a surprise, as the company had previously been a major shareholder in Merit Medical Systems. Merit Medical Systems, Inc. is a leading global manufacturer and marketer of disposable medical devices used primarily in cardiology, radiology, oncology, critical care and endoscopy procedures. The company has a strong presence in both the United States and abroad, offering products that help physicians diagnose and treat medical conditions in numerous healthcare settings. Merit Medical Systems is focused on improving patient care by creating innovative medical devices and providing top-notch customer service. The company strives to maintain the highest standards of quality, safety, and efficiency in all of their products. They are committed to delivering excellent value to their customers and shareholders by focusing on developing and manufacturing products that make healthcare more efficient, cost-effective, and safe.

However, Merit Medical Systems remains committed to developing and delivering innovative medical devices that improve patient care worldwide. With their dedication to quality and customer service, Merit Medical Systems will continue to be a leader in the medical device industry.

Share Price

On Tuesday, MERIT MEDICAL SYSTEMS stock opened at $81.3 and closed at $81.4. The company also recently announced a distribution agreement with B. Braun to bring its products to the European market. Despite the reduction in Victory Capital Management Inc.’s holdings, Merit Medical Systems, Inc. continues to be a strong performer in the medical device industry, with a market capitalization of over $2 billion. As the healthcare industry continues to shift towards increased digitalization, Merit Medical Systems Inc.’s innovative products and services will continue to be in high demand. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for MMSI. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for MMSI. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for MMSI. More…

Key Ratios Snapshot

Some of the financial key ratios for MMSI are shown below. More…

Analysis

At GoodWhale, we recently conducted an analysis of MERIT MEDICAL SYSTEMS’ financials. After a thorough review, we have assigned a medium risk rating to the company in terms of financial and business aspects. We discovered two risk warnings in the income sheet and balance sheet of MERIT MEDICAL SYSTEMS that our users should be aware of. So if you want to learn more about the company’s financials, be sure to register on our website, goodwhale.com. More…

Peers

The company’s products are used in a variety of medical procedures, including cardiovascular, gastrointestinal, urological, and obstetrical/gynecological procedures. The company has a strong competitive position in the medical device market, with a leading market share in many of its product categories.

However, the company faces competition from a number of well-established competitors, including Medeon Biodesign Inc, Pixium Vision SA, and AngioDynamics Inc.

– Medeon Biodesign Inc ($TPEX:6499)

Medeon Biodesign Inc is a medical device company that develops and commercializes products for the treatment of cardiovascular diseases. The company has a market cap of 4.55B and a ROE of -6.27%. Medeon Biodesign Inc’s products are used in the treatment of coronary artery disease, heart failure, and other cardiovascular conditions. The company’s products are sold in over 30 countries worldwide.

– Pixium Vision SA ($OTCPK:PXMVF)

Pixium Vision SA is a French company that designs, develops, and markets bionic vision systems to enable patients who have lost their sight to regain some level of vision. The company’s products include the PRIMA bionic vision system, which consists of an implantable microstimulator and a wearable camera and glasses, and the IRIS II bionic vision system, which consists of an implantable microstimulator and a contact lens. Pixium Vision SA’s products are intended for use in patients with retinitis pigmentosa, macular degeneration, and other degenerative eye diseases.

– AngioDynamics Inc ($NASDAQ:ANGO)

AngioDynamics Inc is a medical device company that designs, manufactures, and sells products used by interventional physicians to treat vascular diseases. The company’s products are used in a variety of procedures, including angioplasty, thrombectomy, ablation, and vascular access. AngioDynamics Inc has a market cap of 549.46M as of 2022, a Return on Equity of -5.11%. The company’s products are used in a variety of procedures, including angioplasty, thrombectomy, ablation, and vascular access. AngioDynamics Inc’s products are sold in over 50 countries worldwide.

Summary

Merit Medical Systems, Inc is an American medical device company that manufactures and markets disposable medical devices. Recently, Victory Capital Management Inc. reduced their holdings in Merit Medical Systems, Inc. This suggests that Victory Capital no longer believes that the stock is favorable for investments. It is important for investors to monitor the performance and fundamentals of Merit Medical Systems, Inc in order to make informed decisions. Investors should consider the company’s financial performance, earnings growth potential, dividend yield, debt and liquidity, and management effectiveness.

Additionally, investors should watch out for any new product launches or strategic decisions that could affect Merit Medical Systems’ long-term growth prospects.